Published in J Infect Dis on July 01, 1987
Rotavirus gene structure and function. Microbiol Rev (1989) 6.95
Rotavirus. Emerg Infect Dis (1999) 2.90
Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun (1991) 1.42
Perspectives on immunoglobulins in colostrum and milk. Nutrients (2011) 1.33
Rotavirus vaccine administered parenterally induces protective immunity. J Virol (1993) 1.27
Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol (2006) 1.22
Human viral gastroenteritis. Clin Microbiol Rev (1989) 1.21
Rotavirus vaccines: an overview. Clin Microbiol Rev (1996) 1.19
Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins. Antimicrob Agents Chemother (1996) 1.17
Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrob Agents Chemother (1997) 1.07
Past, present, and future technologies for oral delivery of therapeutic proteins. J Pharm Sci (2008) 1.05
Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh. EBioMedicine (2016) 0.99
Human Toxoplasma gondii-specific secretory immunoglobulin A reduces T. gondii infection of enterocytes in vitro. J Clin Invest (1992) 0.92
Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol (2007) 0.92
Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells. Clin Exp Immunol (2012) 0.84
Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans. Nutr J (2015) 0.83
Dietary therapy with Lactobacillus GG, bovine colostrum or bovine immune colostrum in patients with juvenile chronic arthritis: evaluation of effect on gut defence mechanisms. Inflammopharmacology (1997) 0.82
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH. J Inflamm Res (2012) 0.82
Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes. Infect Immun (1989) 0.80
Passive immunity against human pathogens using bovine antibodies. Clin Exp Immunol (1999) 0.79
Absorption and safety of serum-derived bovine immunoglobulin/protein isolate in healthy adults. Clin Exp Gastroenterol (2016) 0.79
Oral ingestion of egg yolk immunoglobulin from hens immunized with an enterotoxigenic Escherichia coli strain prevents diarrhea in rabbits challenged with the same strain. Infect Immun (1992) 0.77
Bovine colostral antibody against verotoxin 2 derived from Escherichia coli O157:H7: resistance to proteases and effects in beagle dogs. Comp Med (2009) 0.77
Travellers' diarrhea. Consider enteral immunotherapy. BMJ (1993) 0.75
Oral immunization with xenogeneic antibodies stimulates the production of systemic and mucosal anti-idiotypic antibodies. Immunology (1991) 0.75
Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk. PLoS One (2014) 0.75
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med (1988) 2.04
Isolation and characterization of two distinct human rotavirus strains with G6 specificity. J Clin Microbiol (1992) 2.03
Comparative genomics reveals close genetic relationships between phages from dairy bacteria and pathogenic Streptococci: evolutionary implications for prophage-host interactions. Virology (2001) 1.95
Comparative genomics of Streptococcus thermophilus phage species supports a modular evolution theory. J Virol (1999) 1.84
Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology (1994) 1.81
Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol (2001) 1.51
Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol (1998) 1.48
Nigerian rotavirus serotype G8 could not be typed by PCR due to nucleotide mutation at the 3' end of the primer binding site. Arch Virol (1997) 1.40
Evolution of Streptococcus thermophilus bacteriophage genomes by modular exchanges followed by point mutations and small deletions and insertions. Virology (1998) 1.40
Detection and classification of Streptococcus thermophilus bacteriophages isolated from industrial milk fermentation. Appl Environ Microbiol (1994) 1.38
Molecular ecology of Streptococcus thermophilus bacteriophage infections in a cheese factory. Appl Environ Microbiol (1997) 1.32
Comparison of the lysogeny modules from the temperate Streptococcus thermophilus bacteriophages TP-J34 and Sfi21: implications for the modular theory of phage evolution. Virology (1998) 1.31
Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany. J Infect Dis (1988) 1.31
The structural gene module in Streptococcus thermophilus bacteriophage phi Sfi11 shows a hierarchy of relatedness to Siphoviridae from a wide range of bacterial hosts. Virology (1998) 1.27
Widespread distribution of a group I intron and its three deletion derivatives in the lysin gene of Streptococcus thermophilus bacteriophages. J Virol (2000) 1.27
Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins. Eur J Pediatr (1979) 1.23
Similarly organized lysogeny modules in temperate Siphoviridae from low GC content gram-positive bacteria. Virology (1999) 1.23
Two-dimensional nuclear magnetic resonance spectroscopy. Science (1986) 1.21
Comparative genomics of lactococcal phages: insight from the complete genome sequence of Lactococcus lactis phage BK5-T. Virology (2001) 1.21
Distinct Streptococcus thermophilus bacteriophages share an extremely conserved DNA fragment. Virology (1994) 1.19
The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinoma. Am J Obstet Gynecol (1995) 1.19
Prevalence and serotype specificity of rotavirus antibodies in different age groups of Ecuadorian infants. J Infect Dis (1990) 1.19
Comparative sequence analysis of the DNA packaging, head, and tail morphogenesis modules in the temperate cos-site Streptococcus thermophilus bacteriophage Sfi21. Virology (1999) 1.17
Site-specific spontaneous deletions in three genome regions of a temperate Streptococcus thermophilus phage. Virology (1996) 1.16
Characterization of the lysogeny DNA module from the temperate Streptococcus thermophilus bacteriophage phi Sfi21. Virology (1997) 1.15
Neutralizing antibodies to heterologous animal rotavirus serotypes 5, 6, 7, and 10 in sera from Ecuadorian children. J Clin Microbiol (1991) 1.14
Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr Infect Dis J (1998) 1.14
Comparative genomics of the late gene cluster from Lactobacillus phages. Virology (2000) 1.14
Age-specific prevalence of antibody to enterotoxigenic Escherichia coli in Ecuadorian and German children. J Infect Dis (1990) 1.12
Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis. J Clin Microbiol (1987) 1.10
Seroconversion patterns to four human rotavirus serotypes in hospitalized infants with acute rotavirus gastroenteritis. J Infect Dis (1988) 1.10
The genetic relationship between virulent and temperate Streptococcus thermophilus bacteriophages: whole genome comparison of cos-site phages Sfi19 and Sfi21. Virology (1999) 1.10
Studies on the effect of distamycin A on the DNA dependent RNA polymerase system. Biochem Biophys Res Commun (1971) 1.07
Creation of genome-wide protein expression libraries using random activation of gene expression. Nat Biotechnol (2001) 1.06
A short noncoding viral DNA element showing characteristics of a replication origin confers bacteriophage resistance to Streptococcus thermophilus. Virology (1998) 1.06
Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes. Immunology (1994) 1.06
Differentiation between intracellular and cell surface glycosyl transferases: galactosyl transferase activity in intact cells and in cell homogenate. Proc Natl Acad Sci U S A (1974) 1.05
An outbreak of Acinetobacter calcoaceticus infection in a neonatal care unit. Infection (1990) 1.04
Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus. J Gen Virol (1988) 1.01
A syndrome characterized by corneal opacity, nystagmus, flexion contracture of the elbows, growth failure, and mental retardation. J Pediatr (1966) 1.00
Seroprevalence of immunoglobulin M (IgM) and IgG antibodies to polysaccharides of Streptococcus pneumoniae in different age groups of Ecuadorian and German children. J Clin Microbiol (1992) 1.00
A highly conserved DNA replication module from Streptococcus thermophilus phages is similar in sequence and topology to a module from Lactococcus lactis phages. Virology (1997) 0.99
Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus. J Virol (1990) 0.99
Further characterization of field strains of rotavirus from Nigeria VP4 genotype P6 most frequently identified among symptomatically infected children. J Trop Pediatr (1997) 0.98
Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology (1995) 0.97
The site-specific integration system of the temperate Streptococcus thermophilus bacteriophage phiSfi21. Virology (1997) 0.97
Nonstructural protein 2 (NS2) of respiratory syncytial virus (RSV) detected by an antipeptide serum. Respiration (1995) 0.97
Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial. Scand J Gastroenterol (2000) 0.96
Portable oxygen in chronic obstructive lung disease with hypoxemia and cor pulmonale. A controlled double-blind crossover study. Chest (1975) 0.94
Field trial of an infant formula containing anti-rotavirus and anti-Escherichia coli milk antibodies from hyperimmunized cows. J Pediatr Gastroenterol Nutr (1992) 0.92
Cattle develop neutralizing antibodies to rotavirus serotypes which could not be isolated from faeces of symptomatic calves. J Gen Virol (1991) 0.90
Bovine rotavirus 993/83 shows a third subtype of avian VP7 protein. Virus Genes (1997) 0.90
A synthetic peptide corresponding to the cleavage region of VP3 from rotavirus SA11 induces neutralizing antibodies. J Virol (1988) 0.90
Significant conformational changes in an antigenic carbohydrate epitope upon binding to a monoclonal antibody. Biochemistry (1990) 0.89
Broad-range bacteriophage resistance in Streptococcus thermophilus by insertional mutagenesis. Virology (2000) 0.89
[Studies on the nucleic acid metabolism of monkey kidney tissue culture cells after infection with SV40. 3. Studies on the mechanism of virus-directed DNA-synthesis increases]. Arch Gesamte Virusforsch (1967) 0.89
Characterization of a second bovine rotavirus serotype. Arch Virol (1987) 0.88
Effect of malnutrition in Ecuadorian children on titers of serum antibodies to various microbial antigens. Clin Diagn Lab Immunol (1995) 0.88
Age-related prevalence of serum antibody to respiratory syncytial virus in Ecuadorian and German children. J Infect Dis (1991) 0.87
Reactivity of human serum antibody with lipopolysaccharide O 78 antigen from enterotoxigenic Escherichia coli. Epidemiol Infect (1992) 0.85
Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life. J Clin Microbiol (1993) 0.84
Expression of adhesion molecules (ICAM-1, LFA-3) on human epithelial cells (A549) after respiratory syncytial virus infection. Int Arch Allergy Immunol (1995) 0.84
[Immunological aspects of coeliac disease (author's transl)]. Padiatr Padol (1973) 0.84
Antibody response to polyribosyl-ribitol phosphate antigen of Haemophilus influenzae in Ecuadorian and German children. Clin Diagn Lab Immunol (1994) 0.83
Infectious gastroenteritis does not act as a triggering mechanism for the synthesis of serum IgG antibody to beta-lactoglobulin. J Pediatr Gastroenterol Nutr (1991) 0.83
Mechanism of action of distamycin A and other antibiotics with antiviral activity. Rev Physiol Biochem Pharmacol (1976) 0.83
A multinuclear NMR study of the interactions of cations with proteoglycans, heparin, and Ficoll. J Biol Chem (1986) 0.83
Prevalence of serum neutralizing antibody to serotype 9 rotavirus WI61 in children from South America and central Europe. J Clin Microbiol (1991) 0.83
A model for respiratory syncytial virus (RSV) infection based on experimental aerosol exposure with bovine RSV in calves. Comp Immunol Microbiol Infect Dis (1996) 0.82
Glycopinion: biological significance and methods for the analysis of complex carbohydrates of recombinant glycoproteins. Biotechnol Appl Biochem (1996) 0.82
Bovine rotavirus V1005 a P5, not a P12, type like all viruses in a German survey. J Clin Microbiol (1994) 0.82
Sequence analysis of pigeon, turkey, and chicken rotavirus VP8* identifies rotavirus 993/83, isolated from calf feces, as a pigeon rotavirus. Virology (1995) 0.82
Serotype of Nigerian rotavirus strains. Trop Med Int Health (1997) 0.82
Respiratory syncytial virus infection: its role in aeroallergen sensitization during the first two years of life. Pediatr Allergy Immunol (1996) 0.82
A detailed 1H and 13C NMR study of a repeating disaccharide of hyaluronan: the effects of temperature and counterion type. Carbohydr Res (1993) 0.81
The use of imperfect diagnostic tests had an impact on prevalence estimation. J Clin Epidemiol (2007) 0.81
Antibodies specific for the carboxy-terminal region of the major surface glycoprotein of simian rotavirus (SA11) and human rotavirus (Wa). J Cell Biochem (1986) 0.81
The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. Biochemistry (1999) 0.81
Purification of respiratory syncytial virus F and G proteins. J Chromatogr B Biomed Sci Appl (2000) 0.80
Incorporation of iododeoxyuridine into cellular deoxyribonucleic acid synthesized after infection with simian virus 40. J Virol (1968) 0.80
Cross-reactivity of antibodies against synthetic peptides. J Cell Biochem (1982) 0.80